Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Mylan NV
Watchlist
MergerTalk: Pfizer/Mylan -Don't Overdose on the Sector, but Mylan Over Teva Pair Trade Is Still On
Event-Driven
560 Views
14 Aug 2019 19:39
The recently announced Reverse Morris Trust transaction involving the merger of Pfizer's (PFE US) off-patent business (Upjohn) with Mylan (MYL US)...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 11-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Japan
Equity Bottom-Up
Event-Driven
Philippines
India
Sell / Short Ideas
Unpaywalled Insights
South Korea
Asia Event-Driven
Trending Insights
More »
Prosus Is Elevated Vs. Tencent As The Accretion Trade Unfolds
StubWorld: Japan Post Holdings (6178 JP) Is "Cheap"
Waaree Energies (WAAREEEN IN): Increased Float & Global Index Inclusion
STAR Chip Index Rebalance Preview: Forecast Changes for September
Wuxi XDC Cayman (2268 HK): Soaring Pharma Stocks & Global Index Inclusion
Top Unpaywalled Insights
More »
Crypto Week Unleashes a Bitcoin Blitz and Sparks the Altcoin Catch-Up
The Bunny Returns: Playboy’s Market Comeback
HK Connect SOUTHBOUND Flows (To 18 July 2025); Volumes Strong, Net Buying Decent, Meituan Hot
Curator's Cut: Japan Insurers Vs Banks, the State of the Chinese EV Sector and Asian Ports in Focus
[IO Technicals 2025/29] Near Term Bullish Trend to Persist
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
MergerTalk: Pfizer/Mylan -Don't Overdose on the Sector, but Mylan Over Teva Pair Trade Is Still On
14 Aug 2019
Generic Drug Antitrust Inquiry: A Primer
14 Nov 2016
Mylan N.V. (MYL US): Another Contrarian Pharmaceutical Investment
03 Nov 2016
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.55.0
x